S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy)
- Status
- TERMINATED
- Phase
- PHASE3
Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Evaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or Betamethasone
- Status
- COMPLETED
- Phase
- NA
All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
- Status
- WITHDRAWN
- Phase
- PHASE3
Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dexamethasone for Post Cesarean Delivery Analgesia
- Status
- COMPLETED
- Phase
- PHASE4
Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
- Status
- COMPLETED
- Phase
- PHASE2
Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ovulation Induction With Clomiphene Citrate and Dexamethasone
- Status
- UNKNOWN
- Phase
- PHASE4
IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2